Cargando…
Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737340/ https://www.ncbi.nlm.nih.gov/pubmed/31528778 http://dx.doi.org/10.1016/j.ekir.2019.07.004 |
_version_ | 1783450650742358016 |
---|---|
author | Wish, Jay B. |
author_facet | Wish, Jay B. |
author_sort | Wish, Jay B. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6737340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-67373402019-09-16 Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice? Wish, Jay B. Kidney Int Rep Commentary Elsevier 2019-07-11 /pmc/articles/PMC6737340/ /pubmed/31528778 http://dx.doi.org/10.1016/j.ekir.2019.07.004 Text en © 2019 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Commentary Wish, Jay B. Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice? |
title | Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice? |
title_full | Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice? |
title_fullStr | Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice? |
title_full_unstemmed | Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice? |
title_short | Will There Be a Role for a Short-Acting Biosimilar Erythropoiesis-Stimulating Agent in US Nephrology Practice? |
title_sort | will there be a role for a short-acting biosimilar erythropoiesis-stimulating agent in us nephrology practice? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737340/ https://www.ncbi.nlm.nih.gov/pubmed/31528778 http://dx.doi.org/10.1016/j.ekir.2019.07.004 |
work_keys_str_mv | AT wishjayb willtherebearoleforashortactingbiosimilarerythropoiesisstimulatingagentinusnephrologypractice |